Regulation of platelet arachidonic acid oxygenation by cyclic AMP.
Intracellular cyclic adenosine monophosate (AMP) levels regulate the generation of thromboxane by platelets by inhibiting the hydrolysis of arachidonic acid from membrane phospholipids. However, there is conflicting evidence regarding the role of cyclic AMP in the control of the subsequent oxygenation of arachidonic acid by cyclooxygenase. We studoed the regulation of cyclooxygenase activity by agents that elevate platelet cyclic AMP (dibutyryl cyclic AMP and prostaglandins), measuring arachidonate-induced aggregation, O2 consumption, and malonaldehyde formation. In platelet-rich cyclic AMP. This inhibitory effect of cyclic AMP was absent in gel-filtered platelets suspended in buffer containing 0.5% albumin, and was progressively restored as plasma was added in increasing concentrations. Increasing the albumin concentration in platelet buffer suspensions likewise increased the ability of cyclic AMP to block the arachidonate-induced O2 burst and MDA production. We conclude that (1) the presence of plasma proteins is important in investigating platelet plasma milieu or at least in the presence of physiologic albumin concentrations.
D001095:Arachidonic Acids / Q000378:metabolism*; D001665:Binding Sites; D001792:Blood Platelets / Q000378:metabolism*; D003994:Bucladesine / Q000494:pharmacology; D002850:Chromatography, Gel; D000242:Cyclic AMP / Q000494:pharmacology*; D006801:Humans; D008315:Malondialdehyde; D010101:Oxygen Consumption; D010974:Platelet Aggregation; D012709:Serum Albumin / Q000494:pharmacology
D001095:Arachidonic Acids; D012709:Serum Albumin; D008315:Malondialdehyde; D003994:Bucladesine; D000242:Cyclic AMP